Posts In: Gubba Pharma In E News

Glenmark and BeiGene partner to market cancer drugs in India

Glenmark Specialty S.A. (Glenmark), a subsidiary of Glenmark Pharmaceuticals, announced an exclusive marketing and distribution agreement with BeiGene. Under this agreement, Glenmark will register and...

Continue Reading

Lupin achieves ISO 14001 and ISO 45001 certification

For its manufacturing sites, R&D center and corporate office Lupin announced that all 12 of its manufacturing sites, its R&D Center and corporate office in...

Continue Reading

Alvotech and Dr. Reddy’s partner to commercialize AVT03

Alvotech, a global player in biosimilar medicines, and Dr Reddy’s Laboratories SA, wholly-owned subsidiary of Dr Reddy’s Laboratories, have entered into a license and supply...

Continue Reading

How successful are AI-discovered drugs in clinical trials? A first analysis and emerging lessons

AI techniques are making inroads into the field of drug discovery. As a result, a growing number of drugs and vaccines have been discovered using...

Continue Reading

GST relief for Pharma sector? BIG update likely from GST Council

The Pharma sector is likely to get relief from Goods and Services Tax (GST) – ET NOW has reliably learnt. According to insiders, the GST...

Continue Reading

Zydus receives USFDA approval for Dexamethasone

Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) to market Dexamethasone Tablets USP, 1 mg (USRLD: Dexamethasone Tablets).Dexamethasone...

Continue Reading

New drug export regime to ease quality concerns

Drugs made in India for global markets will soon have their local certification aligned with global norms, as the central government moves to assure foreign...

Continue Reading

Nestlé, Dr. Reddy’s form joint venture to expand nutraceutical portfolio

Nestlé India and Dr. Reddy’s Laboratories Ltd announced that they have entered into a definitive agreement to form a joint venture to bring innovative nutraceutical...

Continue Reading

Indian pharmaceutical industry set for major transformation: Dilip Shanghvi

India’s pharmaceutical industry is set for a significant transformation from being a producer of generic drugs to high-value innovative products. Dilip Shanghvi, MD of Sun...

Continue Reading